CDX2 and gastric adenocarcinoma: Immunohistochemical staining confirmed high CDX2 expression, a known prognostic factor in gastric cancer, in both primary gastric cancer tissues (Figure 6d) and organoids (Figure 6e), consistent with its established role in intestinal metaplasia and gastric adenocarcinoma progression.